| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
1 | AN ACT concerning regulation.
| |||||||||||||||||||
2 | Be it enacted by the People of the State of Illinois,
| |||||||||||||||||||
3 | represented in the General Assembly:
| |||||||||||||||||||
4 | Section 5. The Health Carrier External Review Act is | |||||||||||||||||||
5 | amended by changing Section 65 as follows: | |||||||||||||||||||
6 | (215 ILCS 180/65)
| |||||||||||||||||||
7 | Sec. 65. External review reporting requirements. | |||||||||||||||||||
8 | (a) Each health carrier shall maintain written records in | |||||||||||||||||||
9 | the aggregate, by state, and for each type of health benefit | |||||||||||||||||||
10 | plan offered by the health carrier on all requests for external | |||||||||||||||||||
11 | review that the health carrier received notice from the | |||||||||||||||||||
12 | Director for each calendar year and submit a report to the | |||||||||||||||||||
13 | Director in the format specified by the Director by June 1 | |||||||||||||||||||
14 | March 1 of each year. | |||||||||||||||||||
15 | (a-5) An independent review organization assigned pursuant | |||||||||||||||||||
16 | to this Act to conduct an external review shall maintain | |||||||||||||||||||
17 | written records in the aggregate by state and by health carrier | |||||||||||||||||||
18 | on all requests for external review for which it conducted an | |||||||||||||||||||
19 | external review during a calendar year and submit a report in | |||||||||||||||||||
20 | the format specified by the Director by March 1 of each year. | |||||||||||||||||||
21 | (a-10) The report required by subsection (a-5) shall | |||||||||||||||||||
22 | include in the aggregate by state, and for each health carrier: | |||||||||||||||||||
23 | (1) the total number of requests for external review; |
| |||||||
| |||||||
1 | (2) the number of requests for external review resolved | ||||||
2 | and, of those resolved, the number resolved upholding the | ||||||
3 | adverse determination or final adverse determination and | ||||||
4 | the number resolved reversing the adverse determination or | ||||||
5 | final adverse determination; | ||||||
6 | (3) the average length of time for resolution; | ||||||
7 | (4) a summary of the types of coverages or cases for | ||||||
8 | which an external review was sought, as provided in the | ||||||
9 | format required by the Director; | ||||||
10 | (5) the number of external reviews that were terminated | ||||||
11 | as the result of a reconsideration by the health carrier of | ||||||
12 | its adverse determination or final adverse determination | ||||||
13 | after the receipt of additional information from the | ||||||
14 | covered person or the covered person's authorized | ||||||
15 | representative; and | ||||||
16 | (6) any other information the Director may request or | ||||||
17 | require. | ||||||
18 | (a-15) The independent review organization shall retain | ||||||
19 | the written records required pursuant to this Section for at | ||||||
20 | least 3 years. | ||||||
21 | (b) The report required under subsection (a) of this | ||||||
22 | Section shall include in the aggregate, by state, and by type | ||||||
23 | of health benefit plan:
| ||||||
24 | (1) the total number of requests for external review; | ||||||
25 | (2) the total number of requests for expedited external | ||||||
26 | review;
|
| |||||||
| |||||||
1 | (3) the total number of requests for external review | ||||||
2 | denied; | ||||||
3 | (4) the number of requests for external review | ||||||
4 | resolved, including: | ||||||
5 | (A) the number of requests for external review | ||||||
6 | resolved upholding the adverse determination or final | ||||||
7 | adverse determination; | ||||||
8 | (B) the number of requests for external review | ||||||
9 | resolved reversing the adverse determination or final | ||||||
10 | adverse determination; | ||||||
11 | (C) the number of requests for expedited external | ||||||
12 | review resolved upholding the adverse determination or | ||||||
13 | final adverse determination; and | ||||||
14 | (D) the number of requests for expedited external | ||||||
15 | review resolved reversing the adverse determination or | ||||||
16 | final adverse determination; | ||||||
17 | (5) the average length of time for resolution for an | ||||||
18 | external review; | ||||||
19 | (6) the average length of time for resolution for an | ||||||
20 | expedited external review; | ||||||
21 | (7) a summary of the types of coverages or cases for | ||||||
22 | which an external review was sought, as specified below:
| ||||||
23 | (A) denial of care or treatment (dissatisfaction | ||||||
24 | regarding prospective non-authorization of a request | ||||||
25 | for care or treatment recommended by a provider | ||||||
26 | excluding diagnostic procedures and referral requests; |
| |||||||
| |||||||
1 | partial approvals and care terminations are also | ||||||
2 | considered to be denials); | ||||||
3 | (B) denial of diagnostic procedure | ||||||
4 | (dissatisfaction regarding prospective | ||||||
5 | non-authorization of a request for a diagnostic | ||||||
6 | procedure recommended by a provider; partial approvals | ||||||
7 | are also considered to be denials); | ||||||
8 | (C) denial of referral request (dissatisfaction | ||||||
9 | regarding non-authorization of a request for a | ||||||
10 | referral to another provider recommended by a PCP); | ||||||
11 | (D) claims and utilization review (dissatisfaction | ||||||
12 | regarding the concurrent or retrospective evaluation | ||||||
13 | of the coverage, medical necessity, efficiency or | ||||||
14 | appropriateness of health care services or treatment | ||||||
15 | plans; prospective "Denials of care or treatment", | ||||||
16 | "Denials of diagnostic procedures" and "Denials of | ||||||
17 | referral requests" should not be classified in this | ||||||
18 | category, but the appropriate one above);
| ||||||
19 | (8) the number of external reviews that were terminated | ||||||
20 | as the result of a reconsideration by the health carrier of | ||||||
21 | its adverse determination or final adverse determination | ||||||
22 | after the receipt of additional information from the | ||||||
23 | covered person or the covered person's authorized | ||||||
24 | representative; and | ||||||
25 | (9) any other information the Director may request or | ||||||
26 | require.
|
| |||||||
| |||||||
1 | (Source: P.A. 96-857, eff. 7-1-10; 97-574, eff. 8-26-11.)
| ||||||
2 | Section 99. Effective date. This Act takes effect January | ||||||
3 | 1, 2017.
|